Darius Lakdawalla, PhD

Title(s)Professor Of Pharmaceutical Economics And Public Policy And Quintiles Chair In Pharmaceutical And Regulatory Innovation
SchoolUSC School of Pharmacy
Address635 Downey Way, VPD 414-K
University Park Campus
Los Angeles CA 90089
Phone+1 213 821 7957
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Darius Lakdawalla is a Professor in the University of Southern California (USC) School of Pharmacy and in the Sol Price School of Public Policy, and holds the Quintiles Chair in Pharmaceutical Development and Regulatory Innovation. Dr. Lakdawalla is also Director of Research at the Leonard D. Schaeffer Center for Health Policy and Economics at USC.

    He has been the recipient of the Milken Institute’s Distinguished Economic Research Award for best research in the field of economics, and the recipient of the Garfield Prize for research on the economics of medical innovation. His work has been published in leading journals of economics, medicine, and health policy, and funded by the National Institute of Aging, the National Institute of Child Health and Human Development, and the National Bureau of Economic Research.

    Dr. Lakdawalla is currently a Research Associate in the Health Care and Health Economics programs at the National Bureau of Economic Research, in Cambridge, Mass., and a Visiting Scholar at the American Enterprise Institute. He serves as an Associate Editor at the Review of Economics and Statistics. He is also the former Director of Research at the Bing Center for Health Economics at the RAND Corporation.

    Dr. Lakdawalla received his BS in mathematics and philosophy from Amherst College and his PhD in economics from the University of Chicago.

    Collapse Research 
    Collapse Research Activities and Funding
    Ensuring Access to Novel Alzheimer?s and Dementia Treatments: Evaluating Innovative Payment Approaches
    NIH R01AG062277Sep 30, 2018 - May 31, 2022
    Role: Co-Principal Investigator
    Medical Malpractice, Health Care Costs, and Technology Adoption
    NIH R01AG031544Jun 1, 2009 - May 31, 2014
    Role: Principal Investigator
    EFFECT OF MEDICAL MALPRACTICE ON COSTS &TECH ADOPTION
    NIH R03AG025809Jun 1, 2005 - May 31, 2008
    Role: Principal Investigator
    WHOM DOES MEDICARE BENEFIT
    NIH R01AG021940Aug 15, 2004 - Jan 31, 2009
    Role: Principal Investigator
    Unclaimed Injuries and Workers' Compensation Adequacy
    NIH R03OH007619Sep 1, 2002 - Aug 31, 2005
    Role: Principal Investigator
    The Redistributive Effects of Medicare
    NIH R03AG020266Sep 30, 2001 - Sep 29, 2003
    Role: Principal Investigator
    Age Difference of Spouses and Long-Term Care
    NIH R03AG019900Sep 15, 2001 - Aug 31, 2003
    Role: Principal Investigator
    RAND MiniMedical School for Social Scientists
    NIH R13AG018327Sep 15, 2000 - Dec 31, 2023
    Role: Co-Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Three Pillars of Support for Orphan Drug Programs: Individual Valuations, Societal Valuations, and Anonymous Altruism. Value Health. 2024 Jul 06. Lakdawalla DN, Phelps CE, Nguyen HH. PMID: 38977180.
      View in: PubMed   Mentions:    Fields:    
    2. Societal Preferences for Subsidizing Treatments Targeting Patients With Advanced Illness: A Discrete Choice Experiment. Value Health Reg Issues. 2024 Sep; 43:101003. Baid D, Lakdawalla DN, Finkelstein EA. PMID: 38838425.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Valuing the Societal Impact of Medicines and Other Health Technologies: A User Guide to Current Best Practices. Forum Health Econ Policy. 2024 Jun 01; 27(1):29-116. Shafrin J, Kim J, Cohen JT, Garrison LP, Goldman DA, Doshi JA, Krieger J, Lakdawalla DN, Neumann PJ, Phelps CE, Whittington MD, Willke R. PMID: 39512185; PMCID: PMC11567015.
      View in: PubMed   Mentions:
    4. A Roadmap for Improving Medicare's Application of Coverage With Evidence Development. Value Health. 2024 Sep; 27(9):1191-1195. Lakdawalla D, Tunis S, Neumann P, Whicher D, Zeitler E, Liden B. PMID: 38795958.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. A principled approach to non-discrimination in cost-effectiveness. Eur J Health Econ. 2024 Nov; 25(8):1393-1416. Lakdawalla DN, Doctor JN. PMID: 38411845.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Risk preferences over health: Empirical estimates and implications for medical decision-making. J Health Econ. 2024 Mar; 94:102857. Mulligan K, Baid D, Doctor JN, Phelps CE, Lakdawalla DN. PMID: 38232447.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. Assessment of Medical and Public Assistance Expenditures and Employment Among US Adults With Cancer Diagnoses. JAMA Netw Open. 2023 05 01; 6(5):e2315823. Grabowski DC, Kansal AR, Goldman DP, Lakdawalla DN. PMID: 37234005; PMCID: PMC10220513.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Prescription Drug Advertising and Drug Utilization: The Role of Medicare Part D. J Public Econ. 2023 May; 221. Alpert A, Lakdawalla D, Sood N. PMID: 37275770; PMCID: PMC10237358.
      View in: PubMed   Mentions: 4  
    9. Methods to Adjust Willingness-to-Pay Measures for Severity of Illness. Value Health. 2023 07; 26(7):1003-1010. Phelps CE, Lakdawalla DN. PMID: 36796478.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Recommendations to address key recruitment challenges of Alzheimer's disease clinical trials. Alzheimers Dement. 2023 02; 19(2):696-707. Langbaum JB, Zissimopoulos J, Au R, Bose N, Edgar CJ, Ehrenberg E, Fillit H, Hill CV, Hughes L, Irizarry M, Kremen S, Lakdawalla D, Lynn N, Malzbender K, Maruyama T, Massett HA, Patel D, Peneva D, Reiman EM, Romero K, Routledge C, Weiner MW, Weninger S, Aisen PS. PMID: 35946590; PMCID: PMC9911558.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    11. Access to Disease-Modifying Alzheimer's Therapies: Addressing Possible Challenges Using Innovative Payment Models. Value Health. 2022 Jul 05. Hlávka JP, Tysinger B, Yu JC, Lakdawalla DN. PMID: 35803845; PMCID: PMC9813270.
      View in: PubMed   Mentions:    Fields:    
    12. Value of Reducing Wait Times for Chimeric Antigen Receptor T-Cell Treatment: Evidence From Randomized Controlled Trial Data on Tisagenlecleucel for Diffuse Large B-Cell Lymphoma. Value Health. 2022 08; 25(8):1344-1351. Chen AJ, Zhang J, Agarwal A, Lakdawalla DN. PMID: 35341689.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    13. Impact of non-binding FDA guidances on primary endpoint selection in Alzheimer's disease trials. Alzheimers Dement (N Y). 2022; 8(1):e12280. Yu JC, Hlávka JP, Joe E, Richmond FJ, Lakdawalla DN. PMID: 35356740; PMCID: PMC8943597.
      View in: PubMed   Mentions: 1  
    14. Crosswalk between the Mini-Mental State Examination and the Telephone Interview for Cognitive Status (TICS-27/30/40). Alzheimers Dement. 2022 11; 18(11):2036-2041. Hlávka JP, Yu JC, Lakdawalla DN. PMID: 35103408; PMCID: PMC10373741.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    15. Increased Lifetime Risk of Intestinal Complications and Extraintestinal Manifestations in Crohn's Disease and Ulcerative Colitis. Gastroenterol Hepatol (N Y). 2022 Jan; 18(1):32-43. Lichtenstein GR, Shahabi A, Seabury SA, Lakdawalla DN, Espinosa OD, Green S, Brauer M, Baldassano RN. PMID: 35505770; PMCID: PMC9053498.
      View in: PubMed   Mentions: 6  
    16. Measuring the COVID-19 Mortality Burden in the United States : A Microsimulation Study. Ann Intern Med. 2021 12; 174(12):1700-1709. Reif J, Heun-Johnson H, Tysinger B, Lakdawalla D. PMID: 34543588; PMCID: PMC8462514.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsPHPublic Health
    17. A guide to extending and implementing generalized risk-adjusted cost-effectiveness (GRACE). Eur J Health Econ. 2022 Apr; 23(3):433-451. Lakdawalla DN, Phelps CE. PMID: 34495445; PMCID: PMC8964662.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    18. Challenging Assumptions of Outcomes and Costs Comparing Peritoneal and Hemodialysis. Value Health. 2021 11; 24(11):1592-1602. Lin E, Lung KI, Chertow GM, Bhattacharya J, Lakdawalla D. PMID: 34711359; PMCID: PMC8562882.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    19. Corrigendum to "Health technology assessment with risk aversion in health" [J. Health Econ. 72 (2020) 102346]. J Health Econ. 2021 Jul; 78:102474. Lakdawalla DN, Phelps CE. PMID: 34107319.
      View in: PubMed   Mentions:    Fields:    
    20. Association of Drug Rebates and Competition With Out-of-Pocket Coinsurance in Medicare Part D, 2014 to 2018. JAMA Netw Open. 2021 05 03; 4(5):e219030. Lakdawalla D, Li M. PMID: 33950205; PMCID: PMC8100863.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    21. Two steps forward, one step back: 50 years of societal value from LDL-C-lowering therapies. Am J Manag Care. 2021 04; 27(4):162-168. MacEwan JP, Zhao LM, Everson K, Liu L, Lautsch D, Sun F, Lakdawalla DN. PMID: 33877775.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. The economics of alternative payment models for pharmaceuticals. Eur J Health Econ. 2021 Jun; 22(4):559-569. Hlávka JP, Yu JC, Goldman DP, Lakdawalla DN. PMID: 33725260; PMCID: PMC8169601.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    23. Adoption of Digital Health Technologies in the Practice of Behavioral Health: Qualitative Case Study of Glucose Monitoring Technology. J Med Internet Res. 2021 02 03; 23(2):e18119. May SG, Huber C, Roach M, Shafrin J, Aubry W, Lakdawalla D, Kane JM, Forma F. PMID: 33533725; PMCID: PMC7889421.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    24. Health Technology Assessment With Diminishing Returns to Health: The Generalized Risk-Adjusted Cost-Effectiveness (GRACE) Approach. Value Health. 2021 02; 24(2):244-249. Lakdawalla DN, Phelps CE. PMID: 33518031.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    25. The Social Value of Improvement in Activities of Daily Living among the Advanced Parkinson's Disease Population. Forum Health Econ Policy. 2020 11 25; 23(2):1-23. Sullivan J, Shih TM, van Eijndhoven E, Jalundhwala YJ, Lakdawalla DN, Zadikoff C, Benner J, Marshall TS, Sail KR. PMID: 33984886.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    26. Predicting quantity and quality of life with the Future Elderly Model. Health Econ. 2021 11; 30 Suppl 1:52-79. Ermini Leaf D, Tysinger B, Goldman DP, Lakdawalla DN. PMID: 33026140; PMCID: PMC8075077.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    27. Early Delays in Insurance Coverage and Long-term Use of Home-based Peritoneal Dialysis. Med Care. 2020 07; 58(7):632-642. Lin E, Chertow GM, Bhattacharya J, Lakdawalla D. PMID: 32520837; PMCID: PMC7295012.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    28. Health technology assessment with risk aversion in health. J Health Econ. 2020 07; 72:102346. Lakdawalla DN, Phelps CE. PMID: 32592923; PMCID: PMC7402585.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    29. CAR-T therapy and historical trends in effectiveness and cost-effectiveness of oncology treatments. J Comp Eff Res. 2020 04; 9(5):327-340. Baumgardner JR, Brauer MS, Zhang J, Hao Y, Liu Z, Lakdawalla DN. PMID: 32056442.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    30. Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? J Policy Anal Manage. 2020; 39(3):577-604. Myerson RM, Tucker-Seeley RD, Goldman DP, Lakdawalla DN. PMID: 32612319; PMCID: PMC7318119.
      View in: PubMed   Mentions: 16     Fields:    
    31. Association Between Spending and Outcomes for Patients With Cancer. J Clin Oncol. 2020 02 01; 38(4):323-331. Li M, Lakdawalla DN, Goldman DP. PMID: 31804868; PMCID: PMC6994252.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    32. The effect of functional status impairment on nursing home admission risk among patients with advanced Parkinson's disease. J Med Econ. 2020 Mar; 23(3):297-307. Shih TM, Sail KR, Jalundhwala YJ, Sullivan J, van Eijndhoven E, Zadikoff C, Marshall TS, Lakdawalla DN. PMID: 31779508.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    33. Lifetime Economic Burden of Crohn's Disease and Ulcerative Colitis by Age at Diagnosis. Clin Gastroenterol Hepatol. 2020 04; 18(4):889-897.e10. Lichtenstein GR, Shahabi A, Seabury SA, Lakdawalla DN, Espinosa OD, Green S, Brauer M, Baldassano RN. PMID: 31326606.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    34. The Value of Progression-Free Survival in Metastatic Breast Cancer: Results From a Survey of Patients and Providers. MDM Policy Pract. 2019 Jan-Jun; 4(1):2381468319855386. MacEwan JP, Doctor J, Mulligan K, May SG, Batt K, Zacker C, Lakdawalla D, Goldman D. PMID: 31259249; PMCID: PMC6589981.
      View in: PubMed   Mentions: 7  
    35. Understanding price growth in the market for targeted oncology therapies. Am J Manag Care. 2019 06; 25(6):273-277. Sussell J, Vanderpuye-Orgle J, Vania D, Goertz HP, Lakdawalla D. PMID: 31211554.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    36. Using Information on Patient Adherence to Antipsychotic Medication to Understand Their Adherence to Other Medications. P T. 2019 Jun; 44(6):350-357. Shafrin J, Silverstein AR, MacEwan JP, Lakdawalla DN, Hatch A, Forma FM. PMID: 31160870; PMCID: PMC6534179.
      View in: PubMed   Mentions: 2  
    37. A Flexible Open-Source Decision Model for Value Assessment of Biologic Treatment for Rheumatoid Arthritis. Pharmacoeconomics. 2019 06; 37(6):829-843. Incerti D, Curtis JR, Shafrin J, Lakdawalla DN, Jansen JP. PMID: 30737711.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    38. How Does Treating Chronic Hepatitis C Affect Individuals in Need of Organ Transplants in the United Kingdom? Value Health. 2019 06; 22(6):669-676. Jena AB, Snider JT, Diaz Espinosa O, Ingram A, Sanchez Gonzalez Y, Lakdawalla D. PMID: 31198184.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    39. Healing the poor: The influence of patient socioeconomic status on physician supply responses. J Health Econ. 2019 03; 64:43-54. Chen A, Lakdawalla DN. PMID: 30797112; PMCID: PMC6481618.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    40. Cost variation and savings opportunities in the Oncology Care Model. Am J Manag Care. 2018 12; 24(12):618-623. Baumgardner J, Shahabi A, Zacker C, Lakdawalla D. PMID: 30586495.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    41. Share of Oncology Versus Nononcology Spending in Episodes Defined by the Centers for Medicare & Medicaid Services Oncology Care Model. J Oncol Pract. 2018 11; 14(11):e699-e710. Baumgardner JR, Shahabi A, Linthicum MT, Zacker C, Lakdawalla DN. PMID: 30423271.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    42. Understanding and improving value frameworks with real-world patient outcomes. Am J Manag Care. 2018 11; 24(11):506-509. Jena AB, Chou JW, Yoon L, Aubry WM, Berger J, Burton W, Fendrick AM, Fick DM, Franklin D, Killion R, Lakdawalla DN, Neumann PJ, Patel K, Yee J, Sakurada B, Yu-Isenberg K. PMID: 30452207.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    43. Does knowledge of patient non-compliance change prescribing behavior in the real world? A claims-based analysis of patients with serious mental illness. Clinicoecon Outcomes Res. 2018; 10:573-585. Shafrin J, Bognar K, Everson K, Brauer M, Lakdawalla DN, Forma FM. PMID: 30323635; PMCID: PMC6173173.
      View in: PubMed   Mentions: 5  
    44. Greater Spending Associated with Improved Survival for Some Cancers in OCM-Defined Episodes. J Manag Care Spec Pharm. 2018 Jun; 24(6):504-513. Baumgardner J, Shahabi A, Linthicum M, Vine S, Zacker C, Lakdawalla D. PMID: 29799330; PMCID: PMC10397851.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    45. Medication Adherence Patterns Among Patients with Multiple Serious Mental and Physical Illnesses. Adv Ther. 2018 May; 35(5):671-685. MacEwan JP, Silverstein AR, Shafrin J, Lakdawalla DN, Hatch A, Forma FM. PMID: 29725982; PMCID: PMC5960492.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    46. Defining Elements of Value in Health Care-A Health Economics Approach: An ISPOR Special Task Force Report [3]. Value Health. 2018 02; 21(2):131-139. Lakdawalla DN, Doshi JA, Garrison LP, Phelps CE, Basu A, Danzon PM. PMID: 29477390.
      View in: PubMed   Mentions: 152     Fields:    Translation:Humans
    47. Approaches to Aggregation and Decision Making-A Health Economics Approach: An ISPOR Special Task Force Report [5]. Value Health. 2018 02; 21(2):146-154. Phelps CE, Lakdawalla DN, Basu A, Drummond MF, Towse A, Danzon PM. PMID: 29477392; PMCID: PMC7110784.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    48. A Health Economics Approach to US Value Assessment Frameworks-Summary and Recommendations of the ISPOR Special Task Force Report [7]. Value Health. 2018 02; 21(2):161-165. Garrison LP, Neumann PJ, Willke RJ, Basu A, Danzon PM, Doshi JA, Drummond MF, Lakdawalla DN, Pauly MV, Phelps CE, Ramsey SD, Towse A, Weinstein MC. PMID: 29477394.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    49. Innovative Contracting for Pharmaceuticals and Medicaid's Best-Price Rule. J Health Polit Policy Law. 2018 02 01; 43(1):5-18. Sachs R, Bagley N, Lakdawalla DN. PMID: 28972020.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    50. The Trade-off Between Speed and Safety in Drug Approvals. JAMA Oncol. 2017 11 01; 3(11):1465-1466. Jena AB, Zhang J, Lakdawalla DN. PMID: 27684643.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    51. What do pharmaceuticals really cost in the long run? Am J Manag Care. 2017 Aug; 23(8):488-493. Lakdawalla D, MacEwan JP, Dubois R, Westrich K, Berdud M, Towse A. PMID: 29087143.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    52. Access to credible information on schizophrenia patients' medication adherence by prescribers can change their treatment strategies: evidence from an online survey of providers. Patient Prefer Adherence. 2017; 11:1071-1081. Shafrin J, May SG, Shrestha A, Ruetsch C, Gerlanc N, Forma F, Hatch A, Lakdawalla DN, Lindenmayer JP. PMID: 28721020; PMCID: PMC5499864.
      View in: PubMed   Mentions: 8  
    53. Real-world resource use and costs of haemophilia A-related bleeding. Haemophilia. 2017 Jul; 23(4):e267-e275. Shrestha A, Eldar-Lissai A, Hou N, Lakdawalla DN, Batt K. PMID: 28574162.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    54. Predicting Real-World Effectiveness of Cancer Therapies Using Overall Survival and Progression-Free Survival from Clinical Trials: Empirical Evidence for the ASCO Value Framework. Value Health. 2017 Jul - Aug; 20(7):866-875. Lakdawalla DN, Shafrin J, Hou N, Peneva D, Vine S, Park J, Zhang J, Brookmeyer R, Figlin RA. PMID: 28712615.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    55. The cost of adherence mismeasurement in serious mental illness: a claims-based analysis. Am J Manag Care. 2017 May 01; 23(5):e156-e163. Shafrin J, Forma F, Scherer E, Hatch A, Vytlacil E, Lakdawalla D. PMID: 28810130.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    56. The role of imperfect surrogate endpoint information in drug approval and reimbursement decisions. J Health Econ. 2017 01; 51:1-12. Bognar K, Romley JA, Bae JP, Murray J, Chou JW, Lakdawalla DN. PMID: 27992772.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    57. Patterns of Adherence to Oral Atypical Antipsychotics Among Patients Diagnosed with Schizophrenia. J Manag Care Spec Pharm. 2016 Nov; 22(11):1349-1361. MacEwan JP, Forma FM, Shafrin J, Hatch A, Lakdawalla DN, Lindenmayer JP. PMID: 27783548; PMCID: PMC10397601.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    58. Estimating the Value of New Technologies That Provide More Accurate Drug Adherence Information to Providers for Their Patients with Schizophrenia. J Manag Care Spec Pharm. 2016 Nov; 22(11):1285-1291. Shafrin J, Schwartz TT, Lakdawalla DN, Forma FM. PMID: 27783545; PMCID: PMC10397938.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    59. Reconsidering the economic value of multiple sclerosis therapies. Am J Manag Care. 2016 Nov 01; 22(11):e368-e374. Shih T, Wakeford C, Meletiche D, Sussell J, Chung A, Liu Y, Shim JJ, Lakdawalla D. PMID: 27849348.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    60. Quantifying Gains in the War on Cancer Due to Improved Treatment and Earlier Detection. Forum Health Econ Policy. 2016 Jun 01; 19(1):141-156. Seabury SA, Goldman DP, Gupta CN, Khan ZM, Chandra A, Philipson TJ, Lakdawalla DN. PMID: 31419891.
      View in: PubMed   Mentions: 2     Fields:    
    61. Estimating the future burden of cardiovascular disease and the value of lipid and blood pressure control therapies in China. BMC Health Serv Res. 2016 05 10; 16:175. Stevens W, Peneva D, Li JZ, Liu LZ, Liu G, Gao R, Lakdawalla DN. PMID: 27165638; PMCID: PMC4862139.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    62. Does patient cost sharing for HCV drugs make sense? Am J Manag Care. 2016 May; 22(6 Spec No.):SP188-90. Lakdawalla DN, Linthicum MT, Vanderpuye-Orgle J. PMID: 27266947.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    63. The wider public health value of HCV treatment accrued by liver transplant recipients. Am J Manag Care. 2016 May; 22(6 Spec No.):SP212-9. Jena AB, Stevens W, Gonzalez YS, Marx SE, Juday T, Lakdawalla DN, Philipson TJ. PMID: 27266951.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    64. Value of expanding HCV screening and treatment policies in the United States. Am J Manag Care. 2016 May; 22(6 Spec No.):SP227-35. Linthicum MT, Gonzalez YS, Mulligan K, Moreno GA, Dreyfus D, Juday T, Marx SE, Lakdawalla DN, Edlin BR, Brookmeyer R. PMID: 27266953.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansPHPublic Health
    65. Costs and spillover effects of private insurers' coverage of hepatitis C treatment. Am J Manag Care. 2016 May; 22(6 Spec No.):SP236-44. Moreno GA, Mulligan K, Huber C, Linthicum MT, Dreyfus D, Juday T, Marx SE, Gonzalez YS, Brookmeyer R, Lakdawalla DN. PMID: 27266954.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    66. The value of surrogate endpoints for predicting real-world survival across five cancer types. Curr Med Res Opin. 2016; 32(4):731-9. Shafrin J, Brookmeyer R, Peneva D, Park J, Zhang J, Figlin RA, Lakdawalla DN. PMID: 26743800.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    67. Effect of hospital use of oral nutritional supplementation on length of stay, hospital cost, and 30-day readmissions among Medicare patients with COPD. Chest. 2015 Jun; 147(6):1477-1484. Snider JT, Jena AB, Linthicum MT, Hegazi RA, Partridge JS, LaVallee C, Lakdawalla DN, Wischmeyer PE. PMID: 25357165; PMCID: PMC4451705.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    68. Medication adherence and measures of health plan quality. Am J Manag Care. 2015 Jun 01; 21(6):e379-89. Seabury SA, Lakdawalla DN, Dougherty JS, Sullivan J, Goldman DP. PMID: 26247579.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    69. Clinical evidence inputs to comparative effectiveness research could impact the development of novel treatments. J Comp Eff Res. 2015 May; 4(3):203-213. Eber MR, Goldman DP, Lakdawalla DN, Philipson TJ, Pritchard D, Huesch M, Summers N, Linthicum MT, Sullivan J, Dubois RW. PMID: 25951244.
      View in: PubMed   Mentions:    Fields:    
    70. Evaluating Expected Costs and Benefits of Granting Access to New Treatments on the Basis of Progression-Free Survival in Non-Small-Cell Lung Cancer. JAMA Oncol. 2015 May; 1(2):196-202. Lakdawalla DN, Chou JW, Linthicum MT, MacEwan JP, Zhang J, Goldman DP. PMID: 26181023.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    71. Insurers' Negotiating Leverage and the External Effects of Medicare Part D. Rev Econ Stat. 2015 May 01; 97(2):314-331. Lakdawalla D, Yin W. PMID: 25937676; PMCID: PMC4414344.
      View in: PubMed   Mentions: 3  
    72. Quality-adjusted cost of care: a meaningful way to measure growth in innovation cost versus the value of health gains. Health Aff (Millwood). 2015 Apr; 34(4):555-61. Lakdawalla D, Shafrin J, Lucarelli C, Nicholson S, Khan ZM, Philipson TJ. PMID: 25847636; PMCID: PMC4406284.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    73. Public-Private Partnership as a Path to Affordable Healthcare in Emerging Markets. Forum Health Econ Policy. 2015 Jan 01; 18(1):65-74. Chou JW, Lakdawalla DN, Vanderpuye-Orgle J. PMID: 31419883.
      View in: PubMed   Mentions: 1     Fields:    
    74. The Relationship between Commercial Health Care Prices and Medicare Spending and Utilization. Health Serv Res. 2015 Jun; 50(3):883-96. Romley JA, Axeen S, Lakdawalla DN, Chernew ME, Bhattacharya J, Goldman DP. PMID: 25429755; PMCID: PMC4450935.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    75. Effect of Oral Nutritional Supplements On Hospital Outcomes in Patients Aged 65+ With Congestive Heart Failure. Value Health. 2014 Nov; 17(7):A503. Lakdawalla D, Thornton SJ, Perlroth D, LaVallee C, Linthicum MT, Philipson TJ, Partridge J, Wischmeyer P. PMID: 27201530.
      View in: PubMed   Mentions:    Fields:    
    76. Economic burden of disease-associated malnutrition in China. Asia Pac J Public Health. 2015 May; 27(4):407-17. Linthicum MT, Thornton Snider J, Vaithianathan R, Wu Y, LaVallee C, Lakdawalla DN, Benner JE, Philipson TJ. PMID: 25301845.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    77. Economic burden of community-based disease-associated malnutrition in the United States. JPEN J Parenter Enteral Nutr. 2014 Nov; 38(2 Suppl):77S-85S. Snider JT, Linthicum MT, Wu Y, LaVallee C, Lakdawalla DN, Hegazi R, Matarese L. PMID: 25249028.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    78. Impact of oral nutrition supplements on hospital outcomes in pediatric patients. JPEN J Parenter Enteral Nutr. 2014 Nov; 38(2 Suppl):42S-9S. Lakdawalla DN, Mascarenhas M, Jena AB, Vanderpuye-Orgle J, LaVallee C, Linthicum MT, Snider JT. PMID: 25233942.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    79. Patient Outcomes and Cost Effects of Medicaid Formulary Restrictions on Antidepressants. Forum Health Econ Policy. 2014 Sep 01; 17(2):153-168. Seabury SA, Lakdawalla DN, Walter D, Hayes J, Gustafson T, Shrestha A, Goldman DP. PMID: 31419879.
      View in: PubMed   Mentions: 1     Fields:    
    80. Can Oral Nutritional Supplements Improve Medicare Patient Outcomes in the Hospital? Forum Health Econ Policy. 2014 Sep 01; 17(2):131-151. Lakdawalla DN, Snider JT, Perlroth DJ, LaVallee C, Linthicum MT, Philipson TJ, Partridge JS, Wischmeyer PE. PMID: 31419880.
      View in: PubMed   Mentions: 1     Fields:    
    81. Reforming medicare's dialysis payment policies: implications for patients with secondary hyperparathyroidism. Health Serv Res. 2014 Dec; 49(6):1925-43. Gupta C, Chertow GM, Linthicum MT, Van Nuys K, Belozeroff V, Quarles D, Lakdawalla DN. PMID: 25040130; PMCID: PMC4254132.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    82. Medicaid prior authorization policies and imprisonment among patients with schizophrenia. Am J Manag Care. 2014 Jul; 20(7):577-86. Goldman D, Fastenau J, Dirani R, Helland E, Joyce G, Conrad R, Lakdawalla D. PMID: 25295404.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    83. Are investments in disease prevention complements? The case of statins and health behaviors. J Health Econ. 2014 Jul; 36:151-63. Kaestner R, Darden M, Lakdawalla D. PMID: 24814322; PMCID: PMC4063305.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    84. Medical professional liability risk among US cardiologists. Am Heart J. 2014 May; 167(5):690-6. Mangalmurti S, Seabury SA, Chandra A, Lakdawalla D, Oetgen WJ, Jena AB. PMID: 24766979; PMCID: PMC4153384.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    85. Formulary restrictions on atypical antipsychotics: impact on costs for patients with schizophrenia and bipolar disorder in Medicaid. Am J Manag Care. 2014 Feb 01; 20(2):e52-60. Seabury SA, Goldman DP, Kalsekar I, Sheehan JJ, Laubmeier K, Lakdawalla DN. PMID: 24738555.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    86. Careful use of science to advance the debate on the UK Cancer Drugs Fund. JAMA. 2014 Jan 01; 311(1):25-6. Lakdawalla DN, Jena AB, Doctor JN. PMID: 24381964; PMCID: PMC3887550.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    87. A Cost-Benefit Analysis of Using Evidence of Effectiveness in Terms of Progression Free Survival in Making Reimbursement Decisions on New Cancer Therapies. Forum Health Econ Policy. 2014 Jan 01; 17(1):21-52. Stevens W, Philipson T, Wu Y, Chen C, Lakdawalla D. PMID: 31419878.
      View in: PubMed   Mentions:    Fields:    
    88. Pharmaceutical advertising and Medicare Part D. J Health Econ. 2013 Dec; 32(6):1356-67. Lakdawalla D, Sood N, Gu Q. PMID: 24308884; PMCID: PMC3855652.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    89. The impact of insulin type on severe hypoglycaemia events requiring inpatient and emergency department care in patients with type 2 diabetes. Diabetes Res Clin Pract. 2013 Dec; 102(3):175-82. Solomon MD, Vijan S, Forma FM, Conrad RM, Summers NT, Lakdawalla DN. PMID: 24188928.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    90. The Value of Diagnostic Testing in Personalized Medicine. Forum Health Econ Policy. 2013 Sep 01; 16(2):S87-S99. Goldman DP, Gupta C, Vasudeva E, Trakas K, Riley R, Lakdawalla D, Agus D, Sood N, Jena AB, Philipson TJ. PMID: 31419871.
      View in: PubMed   Mentions: 6     Fields:    
    91. Burden, timing, and relationship of cardiovascular hospitalization to mortality among Medicare beneficiaries with newly diagnosed atrial fibrillation. Am Heart J. 2013 Sep; 166(3):573-80. Turakhia MP, Solomon MD, Jhaveri M, Davis P, Eber MR, Conrad R, Summers N, Lakdawalla D. PMID: 24016509.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    92. Health Insurance as a Two-Part Pricing Contract. J Public Econ. 2013 Jun 01; 102:1-12. Lakdawalla D, Sood N. PMID: 23997354; PMCID: PMC3752927.
      View in: PubMed   Mentions: 2  
    93. Comparative effectiveness of antiarrhythmic drugs on cardiovascular hospitalization and mortality in atrial fibrillation. J Comp Eff Res. 2013 May; 2(3):301-12. Lakdawalla D, Turakhia MP, Jhaveri M, Mozaffari E, Davis P, Bradley L, Solomon MD. PMID: 24236629.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    94. Measuring the value of better diabetes management. Am J Manag Care. 2013 Mar-Apr; 19 Spec No. 2:E11. Lakdawalla D, Eber MR, Forma FM, Sullivan J, Michaud PC, Bradley LA, Goldman DP. PMID: 23725237.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    95. Comparative effectiveness research and formulary placement: the case of diabetes. Am J Manag Care. 2013 02; 19(2):93-6. Chernew ME, McKellar R, Aubry W, Beck R, Benner J, Berger JE, Fendrick AM, Forma F, Goldman D, Peters Harmel A, Killion R, Lakdawalla D, Owens DK, Stahl J. PMID: 23448106.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    96. Impact of oral nutritional supplementation on hospital outcomes. Am J Manag Care. 2013 Feb; 19(2):121-8. Philipson TJ, Snider JT, Lakdawalla DN, Stryckman B, Goldman DP. PMID: 23448109.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    97. On average, physicians spend nearly 11 percent of their 40-year careers with an open, unresolved malpractice claim. Health Aff (Millwood). 2013 Jan; 32(1):111-9. Seabury SA, Chandra A, Lakdawalla DN, Jena AB. PMID: 23297278; PMCID: PMC6385890.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    98. The Welfare Effects of Medical Malpractice Liability. Int Rev Law Econ. 2012 Dec; 32(4):356-369. Lakdawalla DN, Seabury SA. PMID: 23526860; PMCID: PMC3601788.
      View in: PubMed   Mentions: 8  
    99. Freedom to innovate: the perils of centralized medical research. Arch Intern Med. 2012 Nov 26; 172(21):1692-3; author reply 1693. Huesch M, Lakdawalla D. PMID: 23183865.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    100. Coverage and use of cancer therapies in the treatment of chronic myeloid leukemia. Am J Manag Care. 2012 11; 18(11 Suppl):S272-8. Darkow T, Maclean R, Joyce GF, Goldman D, Lakdawalla DN. PMID: 23327459.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    101. Value of survival gains in chronic myeloid leukemia. Am J Manag Care. 2012 11; 18(11 Suppl):S257-64. Yin W, Penrod JR, Maclean R, Lakdawalla DN, Philipson T. PMID: 23327457.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    102. The large social value resulting from use of statins warrants steps to improve adherence and broaden treatment. Health Aff (Millwood). 2012 Oct; 31(10):2276-85. Grabowski DC, Lakdawalla DN, Goldman DP, Eber M, Liu LZ, Abdelgawad T, Kuznik A, Chernew ME, Philipson T. PMID: 23048109.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    103. Outcomes of medical malpractice litigation against US physicians. Arch Intern Med. 2012 Jun 11; 172(11):892-4. Jena AB, Chandra A, Lakdawalla D, Seabury S. PMID: 22825616.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    104. The value of medical and pharmaceutical interventions for reducing obesity. J Health Econ. 2012 Jul; 31(4):630-43. Michaud PC, Goldman DP, Lakdawalla DN, Zheng Y, Gailey AH. PMID: 22705389; PMCID: PMC3600147.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    105. Defense costs of medical malpractice claims. N Engl J Med. 2012 Apr 05; 366(14):1354-6. Seabury S, Chandra A, Lakdawalla D, Jena AB. PMID: 22475613.
      View in: PubMed   Mentions: 7     Fields:    
    106. An analysis of whether higher health care spending in the United States versus Europe is 'worth it' in the case of cancer. Health Aff (Millwood). 2012 Apr; 31(4):667-75. Philipson T, Eber M, Lakdawalla DN, Corral M, Conti R, Goldman DP. PMID: 22492882; PMCID: PMC3829769.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    107. Patients value metastatic cancer therapy more highly than is typically shown through traditional estimates. Health Aff (Millwood). 2012 Apr; 31(4):691-9. Seabury SA, Goldman DP, Maclean JR, Penrod JR, Lakdawalla DN. PMID: 22492885.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    108. How cancer patients value hope and the implications for cost-effectiveness assessments of high-cost cancer therapies. Health Aff (Millwood). 2012 Apr; 31(4):676-82. Lakdawalla DN, Romley JA, Sanchez Y, Maclean JR, Penrod JR, Philipson T. PMID: 22492883.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    109. Does Intellectual Property Restrict Output? An Analysis of Pharmaceutical Markets. J Law Econ. 2012 Feb 01; 55(1):151-187. Lakdawalla D, Philipson T. PMID: 25221349; PMCID: PMC4161291.
      View in: PubMed   Mentions:
    110. Economic instruments for obesity prevention: results of a scoping review and modified Delphi survey. Int J Behav Nutr Phys Act. 2011 Oct 06; 8:109. Faulkner GE, Grootendorst P, Nguyen VH, Andreyeva T, Arbour-Nicitopoulos K, Auld MC, Cash SB, Cawley J, Donnelly P, Drewnowski A, Dubé L, Ferrence R, Janssen I, Lafrance J, Lakdawalla D, Mendelsen R, Powell LM, Traill WB, Windmeijer F. PMID: 21978599; PMCID: PMC3207922.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimals
    111. Malpractice risk according to physician specialty. N Engl J Med. 2011 Aug 18; 365(7):629-36. Jena AB, Seabury S, Lakdawalla D, Chandra A. PMID: 21848463; PMCID: PMC3204310.
      View in: PubMed   Mentions: 213     Fields:    Translation:Humans
    112. Differences in health between Americans and Western Europeans: Effects on longevity and public finance. Soc Sci Med. 2011 Jul; 73(2):254-63. Michaud PC, Goldman D, Lakdawalla D, Gailey A, Zheng Y. PMID: 21719178; PMCID: PMC3383030.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    113. The benefits from giving makers of conventional 'small molecule' drugs longer exclusivity over clinical trial data. Health Aff (Millwood). 2011 Jan; 30(1):84-90. Goldman DP, Lakdawalla DN, Malkin JD, Romley J, Philipson T. PMID: 21209443; PMCID: PMC3804334.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    114. Valuing health technologies at NICE: recommendations for improved incorporation of treatment value in HTA. Health Econ. 2010 Oct; 19(10):1109-16. Goldman D, Lakdawalla D, Philipson TJ, Yin W. PMID: 20842680.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    115. Sexually transmitted diseases among users of erectile dysfunction drugs: analysis of claims data. Ann Intern Med. 2010 Jul 06; 153(1):1-7. Jena AB, Goldman DP, Kamdar A, Lakdawalla DN, Lu Y. PMID: 20621899; PMCID: PMC3673772.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    116. Burden of illness of diabetic macular edema: literature review. Curr Med Res Opin. 2010 Jul; 26(7):1587-97. Chen E, Looman M, Laouri M, Gallagher M, Van Nuys K, Lakdawalla D, Fortuny J. PMID: 20429823.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    117. An economic evaluation of the war on cancer. J Health Econ. 2010 May; 29(3):333-46. Lakdawalla DN, Sun EC, Jena AB, Reyes CM, Goldman DP, Philipson TJ. PMID: 20363520.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansPHPublic Health
    118. Patents, innovation, and the welfare effects of Medicare Part D. Adv Health Econ Health Serv Res. 2010; 22:317-44. Gailey A, Lakdawalla D, Sood N. PMID: 20575239; PMCID: PMC3988702.
      View in: PubMed   Mentions:    Fields:    
    119. The value of specialty oncology drugs. Health Serv Res. 2010 Feb; 45(1):115-32. Goldman DP, Jena AB, Lakdawalla DN, Malin JL, Malkin JD, Sun E. PMID: 19878344; PMCID: PMC2813440.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    120. The growth of obesity and technological change. Econ Hum Biol. 2009 Dec; 7(3):283-93. Lakdawalla D, Philipson T. PMID: 19748839; PMCID: PMC2767437.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    121. Innovation and The Welfare Effects of Public Drug Insurance. J Public Econ. 2009 Apr 01; 93(3-4):541-548. Lakdawalla D, Sood N. PMID: 20454467; PMCID: PMC2865693.
      View in: PubMed   Mentions: 15  
    122. Annual expenditures for nursing home care: private and public payer price growth, 1977 to 2004. Med Care. 2009 Mar; 47(3):295-301. Stewart KA, Grabowski DC, Lakdawalla DN. PMID: 19194339; PMCID: PMC2763425.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    123. The effect of regulation on pharmaceutical revenues: experience in nineteen countries. Health Aff (Millwood). 2009 Jan-Feb; 28(1):w125-37. Sood N, de Vries H, Gutierrez I, Lakdawalla DN, Goldman DP. PMID: 19088100; PMCID: PMC3829766.
      View in: PubMed   Mentions: 18     Fields:    
    124. U.S. pharmaceutical policy in a global marketplace. Health Aff (Millwood). 2009 Jan-Feb; 28(1):w138-50. Lakdawalla DN, Goldman DP, Michaud PC, Sood N, Lempert R, Cong Z, de Vries H, Gutierrez I. PMID: 19088101; PMCID: PMC3804349.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    125. Chronic disease and severe disability among working-age populations. Med Care. 2008 Jan; 46(1):92-100. Bhattacharya J, Choudhry K, Lakdawalla D. PMID: 18162861.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    126. Welfare-Enhancing Technological Change and the Growth of Obesity. Am Econ Rev. 2005 May; 95(2):253-7. Lakdawalla D, Philipson T, Bhattacharya J. PMID: 29125263; PMCID: PMC6280963.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    127. The health and cost consequences of obesity among the future elderly. Health Aff (Millwood). 2005; 24 Suppl 2:W5R30-41. Lakdawalla DN, Goldman DP, Shang B. PMID: 16186149.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    128. Consequences of health trends and medical innovation for the future elderly. Health Aff (Millwood). 2005; 24 Suppl 2:W5R5-17. Goldman DP, Shang B, Bhattacharya J, Garber AM, Hurd M, Joyce GF, Lakdawalla DN, Panis C, Shekelle PG. PMID: 16186147; PMCID: PMC6205231.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    129. Disability forecasts and future Medicare costs. Front Health Policy Res. 2004; 7:75-94. Bhattacharya J, Cutler DM, Goldman DP, Hurd MD, Joyce GF, Lakdawalla DN, Panis CW, Shang B. PMID: 15612336; PMCID: PMC6298747.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    130. Are the young becoming more disabled? Health Aff (Millwood). 2004 Jan-Feb; 23(1):168-76. Lakdawalla DN, Bhattacharya J, Goldman DP. PMID: 15002639.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    131. A response to the points by Manton and Williamson. Med Care. 2003 Jan; 41(1):28-31. Lakdawalla D, Bhattacharya J, Goldman DP. PMID: 12544541.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    132. Forecasting the nursing home population. Med Care. 2003 Jan; 41(1):8-20. Lakdawalla D, Goldman DP, Bhattacharya J, Hurd MD, Joyce GF, Panis CW. PMID: 12544538.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    133. A new method for determining patient payments for outpatient drugs. Am J Manag Care. 2002 Feb; 8(2):125, 128, 130. Goldman DP, Lakdawalla D. PMID: 11853200.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    134. The Rise in Old-Age Longevity and the Market for Long-Term Care. Am Econ Rev. 2002; 92(1):295-306. Lakdawalla D, Philipson T. PMID: 29058393.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    Darius's Networks
    Concepts (369)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (19)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.

    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.